Patrick Povse
YOU?
Author Swipe
View article: B-364 Changing Immunochemistry Platforms: Analytical and Clinical analysis of cancer antigen (CA) 15-3 and 27.29 testing
B-364 Changing Immunochemistry Platforms: Analytical and Clinical analysis of cancer antigen (CA) 15-3 and 27.29 testing Open
Background Tumor marker (TM) testing plays an important role in monitoring chemotherapy response in metastatic breast cancer. While the American Society of Clinical Oncology (ASCO) guidelines consider CA 15-3 and CA 27.29 clinically equiva…
View article: A-078 Harmonization of Immunoassay Reference Intervals with LC-MS/MS for Total and Calculated Free Testosterone Measurement
A-078 Harmonization of Immunoassay Reference Intervals with LC-MS/MS for Total and Calculated Free Testosterone Measurement Open
Background Management of male hypogonadism relies on accurate serum testosterone testing and reference values. This study aimed to establish harmonized reference ranges for total and calculated free testosterone in adults using the Siemens…
View article: Method Performance of Bicarbonate and Electrolytes by Use of Duodenal Fluid for Assessment of Exocrine Pancreatic Function
Method Performance of Bicarbonate and Electrolytes by Use of Duodenal Fluid for Assessment of Exocrine Pancreatic Function Open
Background Evaluation of exocrine pancreatic insufficiency is challenging for both clinicians and laboratories. Indirect pancreatic function tests such as serum trypsinogen, fecal elastase, and fecal fat measurements are moderately sensiti…